← Return to Intraductal Prostate Cancer: Any info about recurrence rates?

Discussion

Intraductal Prostate Cancer: Any info about recurrence rates?

Prostate Cancer | Last Active: Dec 14, 2024 | Replies (25)
Comment receiving replies
@akiwi

( sorry @jeffmarc, Imeant to reply to the OP)

There seem to be 2 types of IDC-P, pattern 1 and pattern 2.

One had a very similar prognosis (for the treatment given in the study) to normal PCa the other was more aggressive. The less aggressive variant was less common: 25-30%.
Can provide a link if you are interested.

I tried asking my urologist what type I have but he got no answer from the pathologist! I will ask for a second opinion from another pathologist.

I decided to add Abiraterone to my ADT because of the aggressive disease.

I am also cT3b N0M0 based on PET PSMA.

Jump to this post

Replies to "( sorry @jeffmarc, Imeant to reply to the OP) There seem to be 2 types of..."
Inactive | @akiwi | Dec 13, 2024

I also have quite a few studies I've collected but they are a bit depressing. 🙁

VIEW AND REPLY
jeffmarc | @jeffmarc | Dec 13, 2024

Just something to think about. If you are on Lupron or Orgovyx Or equivalent and it takes your PSA down to undetectable you may not want to start anything else. Because it can reduce the amount of time that you can stay undetectable or close to it.

I was able to go 2 1/2 years on Lupron before it failed and I became castrate resistant. I then started Zytiga And for 2 1/2 more years, it kept my cancer under control. The combination of drugs, so early may not be beneficial, It’s really hard to say

I’ve been on Darolutamide For almost a year and a half, and it’s kept my cancer undetectable. Getting 2 1/2 years out of Zytiga Was well worth it.

If your cancer has spread, and you have multiple metastasis, then maybe you want to use Triple therapy, which includes chemo.

VIEW AND REPLY